BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

731 related articles for article (PubMed ID: 25400128)

  • 1. RNA-guided transcriptional regulation in planta via synthetic dCas9-based transcription factors.
    Piatek A; Ali Z; Baazim H; Li L; Abulfaraj A; Al-Shareef S; Aouida M; Mahfouz MM
    Plant Biotechnol J; 2015 May; 13(4):578-89. PubMed ID: 25400128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiplexed Transcriptional Activation or Repression in Plants Using CRISPR-dCas9-Based Systems.
    Lowder LG; Paul JW; Qi Y
    Methods Mol Biol; 2017; 1629():167-184. PubMed ID: 28623586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA-guided transcriptional activation via CRISPR/dCas9 mimics overexpression phenotypes in Arabidopsis.
    Park JJ; Dempewolf E; Zhang W; Wang ZY
    PLoS One; 2017; 12(6):e0179410. PubMed ID: 28622347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene transcription repression in Clostridium beijerinckii using CRISPR-dCas9.
    Wang Y; Zhang ZT; Seo SO; Lynn P; Lu T; Jin YS; Blaschek HP
    Biotechnol Bioeng; 2016 Dec; 113(12):2739-2743. PubMed ID: 27240718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA-guided genome editing in plants using a CRISPR-Cas system.
    Xie K; Yang Y
    Mol Plant; 2013 Nov; 6(6):1975-83. PubMed ID: 23956122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPathBrick: Modular Combinatorial Assembly of Type II-A CRISPR Arrays for dCas9-Mediated Multiplex Transcriptional Repression in E. coli.
    Cress BF; Toparlak ÖD; Guleria S; Lebovich M; Stieglitz JT; Englaender JA; Jones JA; Linhardt RJ; Koffas MA
    ACS Synth Biol; 2015 Sep; 4(9):987-1000. PubMed ID: 25822415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. cis-trans Engineering: Advances and Perspectives on Customized Transcriptional Regulation in Plants.
    Shrestha A; Khan A; Dey N
    Mol Plant; 2018 Jul; 11(7):886-898. PubMed ID: 29859265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Robust Transcriptional Activation in Plants Using Multiplexed CRISPR-Act2.0 and mTALE-Act Systems.
    Lowder LG; Zhou J; Zhang Y; Malzahn A; Zhong Z; Hsieh TF; Voytas DF; Zhang Y; Qi Y
    Mol Plant; 2018 Feb; 11(2):245-256. PubMed ID: 29197638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evaluation of active transcriptional repressor domain for CRISPRi in plants.
    Xu L; Sun B; Liu S; Gao X; Zhou H; Li F; Li Y
    Gene; 2023 Jan; 851():146967. PubMed ID: 36261092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modularized CRISPR/dCas9 effector toolkit for target-specific gene regulation.
    Agne M; Blank I; Emhardt AJ; Gäbelein CG; Gawlas F; Gillich N; Gonschorek P; Juretschke TJ; Krämer SD; Louis N; Müller A; Rudorf A; Schäfer LM; Scheidmann MC; Schmunk LJ; Schwenk PM; Stammnitz MR; Warmer PM; Weber W; Fischer A; Kaufmann B; Wagner HJ; Radziwill G
    ACS Synth Biol; 2014 Dec; 3(12):986-9. PubMed ID: 25524106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stabilization of Foxp3 expression by CRISPR-dCas9-based epigenome editing in mouse primary T cells.
    Okada M; Kanamori M; Someya K; Nakatsukasa H; Yoshimura A
    Epigenetics Chromatin; 2017; 10():24. PubMed ID: 28503202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR-Mediated Activation of Endogenous Gene Expression in the Postnatal Heart.
    Schoger E; Carroll KJ; Iyer LM; McAnally JR; Tan W; Liu N; Noack C; Shomroni O; Salinas G; Groß J; Herzog N; Doroudgar S; Bassel-Duby R; Zimmermann WH; Zelarayán LC
    Circ Res; 2020 Jan; 126(1):6-24. PubMed ID: 31730408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applications of Engineered DNA-Binding Molecules Such as TAL Proteins and the CRISPR/Cas System in Biology Research.
    Fujita T; Fujii H
    Int J Mol Sci; 2015 Sep; 16(10):23143-64. PubMed ID: 26404236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional reprogramming in yeast using dCas9 and combinatorial gRNA strategies.
    Jensen ED; Ferreira R; Jakočiūnas T; Arsovska D; Zhang J; Ding L; Smith JD; David F; Nielsen J; Jensen MK; Keasling JD
    Microb Cell Fact; 2017 Mar; 16(1):46. PubMed ID: 28298224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome engineering via TALENs and CRISPR/Cas9 systems: challenges and perspectives.
    Mahfouz MM; Piatek A; Stewart CN
    Plant Biotechnol J; 2014 Oct; 12(8):1006-14. PubMed ID: 25250853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Programmable CRISPR-Cas transcriptional activation in bacteria.
    Ho HI; Fang JR; Cheung J; Wang HH
    Mol Syst Biol; 2020 Jul; 16(7):e9427. PubMed ID: 32657546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR RNA-guided activation of endogenous human genes.
    Maeder ML; Linder SJ; Cascio VM; Fu Y; Ho QH; Joung JK
    Nat Methods; 2013 Oct; 10(10):977-9. PubMed ID: 23892898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A CRISPR Interference Platform for Efficient Genetic Repression in
    Wensing L; Sharma J; Uthayakumar D; Proteau Y; Chavez A; Shapiro RS
    mSphere; 2019 Feb; 4(1):. PubMed ID: 30760609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repurposing CRISPR System for Transcriptional Activation.
    Chen M; Qi LS
    Adv Exp Med Biol; 2017; 983():147-157. PubMed ID: 28639197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR-Cas-mediated targeted genome editing in human cells.
    Yang L; Mali P; Kim-Kiselak C; Church G
    Methods Mol Biol; 2014; 1114():245-67. PubMed ID: 24557908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.